Preclinical development of a pan Bcl2 inhibitor for cancer stem cell directed therapy
Cancer is the leading cause of death for individuals under 85. Relapse and metastatic disease are the leading causes of cancer related mortality. Anti-apoptotic BCL2 family member overexpression has been…